YFYu. V. Fomicheva

Yu. V. Fomicheva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu. V. Fomicheva has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Titin Serum Level Is Elevated in Patients with Myocarditis Depending on Their Genetic Background

    by Yuriy Vakhrushev, Sofia Mayrina, Sofiya Andreeva, Yulia Vlasova, Yulia Fomicheva, Darina Sambur, Lubov Mitrofanova, Olga Moiseeva, Anna Kostareva

    Background: The molecular basis of myocarditis is often associated with genetic cardiomyopathies and truncating or loss-of-function variants in the titin gene (TTNtv/lof). Here, we hypothesize that titin serum levels increase in patients with myocarditis, and that this can depend on the genetic background of the disease. Methods: Forty-six patients with myocarditis were included in this study. Genotyping was performed using targeted panel sequencing. Serum titin levels and titin/creatinine ratios were measured in a subgroup of 27 patients. Results: Overall, 47 gene variants were identified, including 13 pathogenic and likely pathogenic variants and 34 variants of uncertain significance. The frequency of TTNtv/lof in patients with myocarditis was 11%. We detected significant differences between the TTNtv/lof group and the genotype-negative group in sustained ventricular tachycardia prevalence, myocardial reverse remodeling (∆ end-diastolic volume) and the prevalence of myocardial necrosis. Serum titin level was elevated in patients with myocarditis, negatively correlated with left ventricular ejection fraction, and was associated with ventricular arrhythmias and a low rate of myocardial reverse remodeling. Conclusions: In patients with biopsy-proven myocarditis, the rate of loss-of-function (LOF) variants was 28%, with a predominance of variants in structural and cytoskeletal genes, and TTNtv/lof variants were detected in 11% of patients. TTNtv/lof variant carriers were characterized by fewer morphological signs of inflammation and more favorable myocardial reverse remodeling. Serum titin levels were elevated in patients with myocarditis. Genotype-negative status of patients was characterized by the highest serum titin levels and titin/creatinine ratios, a lesser degree of myocardial reverse remodeling, sustained ventricular arrhythmias, and a larger area of necrosis.

  • Open Access

    Potential and prospects for using biomedical resource collections obtained from pediatric patients for clinics and research

    by О. В. Мельник, A. M. Zlotina, S. G. Fetisova, Yu. V. Fomicheva, П. С. Сокольникова, A. A. Kolesov, T. L. Vershinina, E. S. Vasichkina, A. A. Kostareva, A. O. Konradi

    Aim . To demonstrate the development and potential applications of bio­medical resource collections of pediatric patient biomaterials, as well as the potential for their differentiated use for clinical and research pur­poses in a multidisciplinary hospital setting at a federal research center. Material and methods . The study included biomaterial from pediatric pa­tients and their first-­degree relatives, banked between 2016 and 2025 as part of research projects at the Almazov National Medical Re­search Center in the field of clinical genetics and pediatrics. De­oxy­ri­bo­nucleic acid (DNA) isolated from whole blood samples and dried blood spots was used for genetic testing using modern molecular genetic dia­gnos­tic methods. Results . The potential of using bioresource collections of pediatric pa­tient biomaterial was demonstrated using familial cases of rare mo­no­genic diseases, for which previously collected biomaterial from the biobank was used to establish a diagnosis and determine follow-up strategies for family members, identify risks to future offspring, and re­ceive advance data on the management of patients with spe­ci­fic he­re­ditary syndromes. Additionally, the ability to predict new phe­no­ty­pes associated with a known gene, and conversely, to uncover the rela­tion­ship of new genes with a known phenotype, was demonstrated using examp­les of familial diseases, where biobank biomaterial enabled seg­re­gation analysis. Using biomaterial from cohorts of patients with a specific pathology, the potential for developing novel diagnostic al­go­rithms and laboratory test systems, a differentiated approach to se­lec­ting a targeted genetic panel for diagnosis, and the identification of new clinical and genetic disease features was showed. A founder mu­ta­tion was showed to be identified in a pathology determined in a spe­cific ethnic group, with the potential to describe the onset time and geo­graphic distribution. Conclusion . The creation of bioresource collections obtained from pediatric populations is a complex, yet extremely important, clini­cal­ly necessary, and promising scientific task. Its implementation faci­li­tates translational research aimed at improving diagnostic methods, under­stan­ding the pathogenesis and progression of childhood diseases, and the influence of environmental factors on their development. It also faci­litates the search for new genetic causes of hereditary pathologies and the description of new phenotypes associated with known genes. It also identifies predictors of disease severity and prognosis. In the long term, it facilitates the search for novel therapeutic approaches and under­stan­ding the disease pathogenesis in adults.

  • Phenotypic heterogeneity of Charcot–Marie–Tooth type 2A disease associated with the c.1091G>C missense mutation (p.Arg364Pro) in the MFN2 gene

    by T.M. Alekseeva, A.I. Vlasenko, V.S. Demeshenok, T.A. Pavlova, A.YU. Smirnova, Yu.V. Fomicheva, A.A. Kostareva

    Charcot–Marie–Tooth disease belongs to the group of genetically and phenotypically heterogeneous sensory-motor polyneuropathies. Charcot–Marie–Tooth disease type 2A (CMT2A) is the most common axonal form of the disease caused by mutations in the mitofusin-2 gene (MFN2). More than 100 missense mutations in this gene have been registered to date. Many studies have demonstrated the variability of clinical presentation depending on the specific localization of the substitution. The presented clinical case shows the peculiarities of the phenotype of a patient with CMT2A disease associated with the c.1091G>C (p.Arg364Pro) missense mutation in the MFN2 gene.

  • Open Access

    Comparative informativeness of various targeted panels in the genetic diagnosis of hypertrophic cardiomyopathy in children

    by S. Г. Fetisova, О. В. Мельник, Y. V. Fomicheva, П. С. Сокольникова, V. G. Abbyasova, O. V. Fedorova, A. A. Kostareva, E. S. Vasichkina

    Introduction. Hypertrophic cardiomyopathy (HCM) is the most common form of cardiomyopathy (CMP). Myocardial hypertrophy in children is associated with a large heterogeneous group of diseases with a high representation of non-sarcomeric causes. Purpose. The study compares diagnostic information from targeted next-generation sequencing (NGS) panels with different gene sets for HCM in children. Materials and methods. A molecular genetic study was conducted using two targeted panels (172 and 39 genes), followed by an assessment of their effectiveness. Results. The study included 53 children with HCM, the median age of which was 10 ± 3.5; 14.0 years. 13 children were examined using a large cardiac panel containing 172 genes. The remaining 40 patients were examined using a targeted panel for HCM containing 39 genes, while in 10 cases (25.0 %) genetic diagnostics was uninformative. Pathogenic and likely pathogenic variants in various genes were detected in 35 (66.0 %) patients. The informativeness of genetic diagnostics in the group of children under one year old was 60.7 %, in the group with onset at the age of over one year — 69.2 %. Conclusion. It is advisable to use an extended cardio panel for NGS for the purpose of genetic diagnosis of HCM in patients with the onset of the disease in the first year of life and small target panels for HCM in patients with the onset at an older age.


  • Open Access

    The Role of NOTCH Pathway Genes in the Inherited Susceptibility to Aortic Stenosis

    by Olga Irtyuga, Rostislav Skitchenko, Mary Babakekhyan, Dmitrii Usoltsev, Svetlana Tarnovskaya, Anna Malashicheva, Yulya Fomicheva, Oksana Rotar, Olga Moiseeva, Ulyana Shadrina, et al.

    The NOTCH-signaling pathway is responsible for intercellular interactions and cell fate commitment. Recently, NOTCH pathway genes were demonstrated to play an important role in aortic valve development, leading to an increased calcified aortic valve disease (CAVD) later in life. Here, we further investigate the association between genetic variants in the NOTCH pathway genes and aortic stenosis in a case–control study of 90 CAVD cases and 4723 controls using target panel sequencing of full-length 20 genes from a NOTCH-related pathway (DVL2, DTX2, MFNG, NUMBL, LFNG, DVL1, DTX4, APH1A, DTX1, APH1B, NOTCH1, ADAM17, DVL3, NCSTN, DTX3L, ILK, RFNG, DTX3, NOTCH4, PSENEN). We identified a common intronic variant in NOTCH1, protecting against CAVD development (rs3812603), as well as several rare and unique new variants in NOTCH-pathway genes (DTX4, NOTCH1, DTX1, DVL2, NOTCH1, DTX3L, DVL3), with a prominent effect of the protein structure and function.


  • Open Access

    Left ventricular noncompaction associated with titin-truncating variants in the TTN gene

    by Yu. A. Vakhrushev, T. I. Vershinina, P. A. Fedotov, A. A. Kozyreva, A. M. Kiselev, Yu. V. Fomicheva, E. S. Vasichkina, T. M. Pervunina, A. A. Kostareva, Ю. А Вахрушев

    Aim. To study the association of genetic variants in the titin gene ( TTN ) with the development and clinical course of left ventricular noncompaction in different age groups. Material and methods. The article discusses three clinical cases of patients with left ventricular noncompaction who were treated at theAlmazovNationalMedicalResearchCenter. We performed a new-generation sequencing of 108 genes associated with cardiomyopathies, as well as whole exome sequencing and Sanger sequencing. Results. We identified genetic variants in the TTN gene leading to the synthesis of truncated protein: in the first two cases, the cause of noncompaction was a thirteen nucleotide deletion with a reading frame shift, in the second, a nonsense mutation. An algorithm for assessing the pathogenicity of the identified variants and a scheme of diagnostic genetic search are presented. Conclusion. Causal role of TTN -truncating variants in development of cardiomyopathies and, in particular, left ventricular noncompaction, requires a comprehensive clinical, segregation and bioinformatic analysis using international databases and the use of bioinformatics software.


  • FEATURES OF THE CLINICAL PHENOTYPE OF FILAMINE CARDIOMYOPATHIES WITH A DEBUT IN EARLY CHILDHOOD

    by T.L. Vershinina, Yu.V. Fomicheva, E.S. Vasichkina, A.S. Muravyov, A.I. Churkina, O.V. Melnik, A.M. Kiselev, T.M. Pervunina, A.A. Kostareva

    Облако Mail.ru - это ваше персональное надежное хранилище в интернете.


  • Open Access

    Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy

    by A. M. Kiselev, T. L. Vershinina, S. I. Tarnovskaya, E. V. Yakovleva, L. Butish, Yu. V. Fomicheva, P. A. Fedotov, A. A. Kozyreva, Yu. A. Vakhrushev, A. K. Latypov, et al.

    Варианты в гене RBM20 у пациентов детского возраста с дилатационной кардиомиопатией


  • Open Access

    Clinical and diagnostic difficulties in management of patients with laminopathies

    by О. В. Мельник, A. B. Malashicheva, Yu. V. Fomicheva, A. A. Khudyakov, A. Ya. Gudkova, D. I. Rudenko, M. A. Simonenko, Е. N. Mikhailov, D. S. Lebedev, E. S. Vasichkina, et al.

    Клинико-диагностические сложности при ламинопатиях


  • Open Access

    BARTH SYNDROME IN PRACTICE OF CARDIOLOGY

    by О. В. Мельник, T. S. Loevets, T. L. Vershinina, A. Ya. Gudkova, Yu. V. Fomicheva, A. A. Kostareva, T. M. Pervunina, Елена Сергеевна Васичкина

    СИНДРОМ БАРТА В ПРАКТИКЕ КАРДИОЛОГА